Browse drugs

…Background Levetiracetam is a commonly used first line anti-epileptic drug (AED) in the …

…atogenesis. Given the major regulatory implications of paternal valproate safety, the recent emergence of new population-based data, and …

…specially with drugs that have narrow therapeutic range such as sodium valproate, thus requiring therapeutic drug monitoring. On the other hand,…

…Valproate, Lamotrigine and Levetiracetam are commonly used anti-seizures medications. Prescribing restri…

…ort included 463 and 1109, respectively. Compared with paternal lamotrigine/levetiracetam monotherapy, paternal valproate exposure was not …

… fever or trauma. Initial cranial CT excluded acute stroke, and levetiracetam dose was decreased (500 mg/48h) as it can cause lethargy. Withi…

…rbazepine, phenobarbital, phenytoin, topiramate, valproate, and zonisamide. The reference group consisted of pregnant patients with diagno…

…Combined toxicity of lacosamide and levetiracetam is uncommon. A man with epilepsy presented with reduced conscio…

…arbital remains the first-line therapy in our NICU, followed by levetiracetam. Lidocaine has proven to be an effective and safe third-line th…

…ospective studies evaluating seizure control outcomes following valproate withdrawal are needed to assess the impact of these regulatory …

…24). Epilepsy group was defined as ICD-10 G40, ICD-10 R56.9, or levetiracetam exposure. In a reciprocal analysis, adults meeting the epilepsy…

…rmatogenesis were no different to those taking levetiracetam or lamotrigine. The authors demonstrate how this aligns with several other pop…